|
|
||||||||
Ann Thorac Surg 1997;64:678-683
© 1997 The Society of Thoracic Surgeons
Divisions of Cardiac Surgery and Cardiology, Ospedale San Carlo, Potenza, Italy
Accepted for publication March 7, 1997.
| Abstract |
|---|
|
|
|---|
Methods. The patients were divided into three groupsurgent, emergent A, and emergent Bon the basis of the evolution of the clinical pattern of the acute coronary insufficiency syndrome on full medical treatment. The three categories were defined as follows: urgent (257 patients), surgical revascularization could be delayed for 24 to 36 hours after surgical consultation because of adequate control of ischemia; emergent A (127 patients), prompt myocardial revascularization was required because medical treatment achieved only transient regression of an unrelenting ischemic pattern; and emergent B (60 patients), prompt myocardial revascularization was required because the acute coronary insufficiency was entirely refractory to medical treatment.
Results. Mortality rates were 7.4% for the urgent group, 13.4% for the emergent A group, and 31.7% for the emergent B group. Multivariate analysis identified the following as risk factors for hospital mortality: ejection fraction (p = 0.023) and aortic cross-clamp time (p = 0.10) for the urgent group; aortic cross-clamp time (p = 0.017), ejection fraction (p = 0.03), and nonuse of blood cardioplegia (p = 0.04) for the emergent A group; and cardiogenic shock (p = 0.00), preoperative ischemic interval (p = 0.00), aortic cross-clamp time (p = 0.018), and nonuse of blood cardioplegia (p = 0.012) for the emergent B group.
Conclusions. A more exact definition of patient risk can be achieved when predictive outcome models are constructed using the risk factors specifically related to each level of clinical severity of the ischemic syndrome.
| Introduction |
|---|
|
|
|---|
| Material and Methods |
|---|
|
|
|---|
Cardiogenic shock was defined as the clinical state of hypoperfusion characterized by systolic pressure lower than 80 mm Hg and central filling pressure greater than 20 mm Hg or cardiac index of less than 1.8 L min-1 m-2. Low cardiac output was considered present when clinical signs of hypoperfusion were associated with elevated central venous and pulmonary capillary pressures, mean systemic pressure of less than 70 mm Hg, cardiac index lower than 2.0 L min-1 m-2, and metabolic acidosis. The diagnosis of perioperative myocardial infarction was made on the basis of the presence of at least two of the following: new Q waves on the electrocardiogram, values of the MB fraction greater than 10% of the total creatine kinase values, and new left ventricular akinetic areas in the postoperative echocardiogram. Full medical treatment included intravenous administration of nitroglycerin, calcium antagonist, and heparin sodium.
Patient Population
Between January 1, 1985, and December 31, 1992, a consecutive series of 444 patients underwent surgical myocardial revascularization for ACI. Patients were divided into three groups on the basis of the preoperative clinical and electrocardiographic evolution patterns of the ischemic syndrome. The first group, the urgent group, comprised 257 patients in whom full medical treatment achieved adequate control of ischemia. Generally, these patients had operation within 24 to 36 hours after surgical consultation because subsequent mild episodes of recurrent ischemia were thought not to require emergent revascularization. The second group, the emergent A group, consisted of 127 patients who required prompt myocardial revascularization because of inadequate control of ischemia. An unrelenting ischemic pattern, interrupted by transient periods of regression, was the usual feature characterizing this group of patients. The third group, the emergent B group, comprised 60 patients with ongoing ischemia. It lasted from the inception of the clinical presentation of the syndrome or, less frequently, persisted for at least 30 minutes before the institution of cardiopulmonary bypass.
Demographics and clinical characteristics of each group are summarized in Table 1
. In particular, the coronary angiogram revealed that thrombus was the ischemia-producing lesion in 58 patients (10 in the urgent group, 9 in the emergent A group, and 39 in the emergent B group); 19 of these patients received thrombolytic treatment. In 73 patients with diffuse coronary artery disease (22 in the emergent A group and 51 in the urgent group), the culprit lesion could not be identified, even when electrocardiographic or wall motion abnormalities were considered. Regarding noncardiac comorbidity, the incidences of diabetes (22%), chronic obstructive pulmonary disease (9%), renal failure (2.6%), and previous cerebral vascular accident (4%) were closely matched in the three groups.
|
Surgical Techniques
Operative data are given in Table 2
. Cardiopulmonary bypass was instituted using an ascending aortic cannula and a two-stage single venous cannula. Moderate hemodilution (hematocrit, 20% to 25%), moderate systemic hypothermia (28°C), and a flow of 2.5 L min-1 m-2 were maintained. Three types of myocardial protection were employed during the study period: St. Thomas I crystalloid cardioplegic solution [3] was used in 298 patients in urgent and emergent A groups and in 36 patients in the emergent B group; blood cardioplegia with cold induction [4] was used in 86 patients in the urgent and emergent A groups; and blood cardioplegia with warm induction and substrate enrichment [4] was used in 24 patients in the emergent B group. The cardioplegic solutions were administered in an antegrade fashion through the aortic root and through the proximal ends of the grafts.
|
2 test was used to detect any significant correlation between outcome and surgical priority. Multivariate logistic regression analysis was used to select the model of variables with the highest predictive power for the event death. Only variables with a p value of less than 0.05 for improvement in
2 were included in the model. All calculations were made using a standard statistical program (BMDP Statistical Software, Los Angeles, CA). | Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
| Comment |
|---|
|
|
|---|
Teoh and coauthors [8] reported an operative mortality rate of 8.5% for urgent surgical revascularization. Classified as urgent were all patients with unstable angina operated on within 72 hours of catheterization. There was no mention of the impact of emergency operation on mortality.
Fremes and associates [9] found an operative mortality rate of 9.2% for patients with unstable angina who needed urgent revascularization. Those authors stated, however, that "certain important characteristics have not been investigated throughout the study period such as emergent as opposed to urgent revascularization."
The markedly higher mortality rate of 14.5% reported by Edwards and colleagues [10] was explained by them as a consequence of the exclusion of all patients in whom revascularization had been deferred up to 24 hours after surgical consultation: only patients with ongoing ischemia were considered to need emergent coronary artery bypass grafting, but no mention was made about preoperative hemodynamic conditions.
Therefore, to categorize comparable subsets of patients and to detect a more reliable prognostic stratification of the surgical risk, uniform criteria identifying different levels of severity of ACI syndrome need to be defined. In our study, when ACI was adequately controlled, although not completely, patients were considered as representing the first degree of clinical severity and consequently were grouped as urgent. Patients showing an ischemic pattern characterized by unrelenting ischemia interrupted by periods of transient regression were considered as belonging to the second degree of clinical severity and were grouped as emergent A. Finally, patients with ongoing ischemia lasting throughout the preoperative period or for at least 30 minutes before the institution of cardiopulmonary bypass were considered as belonging to the third degree of clinical severity and grouped as emergent B.
The validity of this stratification is confirmed by the different mortality rates observed (see Table 3
). Moreover, in regard to the first two groups, the risk factors prolonged aortic cross-clamp time and low ejection fraction carry a significantly worse prognostic weight for the emergent A group than the urgent group (see Figs 1, 2![]()
). Also, the risk factor nonuse of blood cardioplegia increases mortality exclusively in the emergent A group (see Table 5
). It can be inferred that within this last group, recent repeated ischemic episodes, albeit brief, may cause prolonged metabolic alterations [11], thus increasing myocardial vulnerability; therefore, the better results obtained with the use of blood cardioplegia may be related to improvement in metabolic conditions (Fig 4
).
|
In conclusion, granted that the exact definition of patient risk factors and the identification of new risk factors make the interpretation of the outcome data clearer, our study supports three major conclusions. First, the exact definition of urgent surgical priority excludes patients undergoing semielective revascularization procedures. Including them would lead to better results, thus giving the impression of low mortality rates in a high-risk category of patients. Second, in ACI syndrome, emergent A surgical priority must be considered a new and important risk factor in the assessment of the exact risk-adjusted patient outcome. Including patients with emergent A surgical priority with high-risk patients undergoing emergency bypass would permit a lower risk-adjusted mortality. Third, results related to the various degrees of severity of the ACI syndrome must be weighed against the type of myocardial protection employed.
| Acknowledgments |
|---|
|
|
|---|
We thank Dr Gerald M. Lemole for his encouragement and his helpful advice in the preparation of this report.
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. J. Rastan, O. Akhavuz, and F. W. Mohr Chapter 46 Coronary artery bypass graft surgery The ESC Textbook of Acute and Intensive Cardiac Care, December 1, 2010; 1(1): med-9780199584314-chapter - med-9780199584314-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Danner, V. N. Didilis, T. Stojanovic, A. Popov, M. Grossmann, R. Seipelt, and F. A. Schondube A Three-Group Model to Predict Mortality in Emergent Coronary Artery Bypass Graft Surgery Ann. Thorac. Surg., November 1, 2009; 88(5): 1433 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Lin, S. Xirasagar, N.-W. Tsao, Y.-T. Hwang, N.-W. Kuo, and H.-C. Lee Volume-outcome relationships in coronary artery bypass graft surgery patients: 5-year major cardiovascular event outcomes. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 923 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Rastan, J. I. Eckenstein, B. Hentschel, A. K. Funkat, J. F. Gummert, N. Doll, T. Walther, V. Falk, and F. W. Mohr Emergency Coronary Artery Bypass Graft Surgery for Acute Coronary Syndrome: Beating Heart Versus Conventional Cardioplegic Cardiac Arrest Strategies Circulation, July 4, 2006; 114(1_suppl): I-477 - I-485. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Stamou, P. C. Hill, E. Haile, S. Prince, M. J. Mack, and P. J. Corso Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 28 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-A. Hassantash, K. Mirpoor, and M. Afrakhteh Cardiac Surgery in an Iranian Teaching Hospital: Outcome and Risk Factors Asian Cardiovasc Thorac Ann, December 1, 2004; 12(4): 312 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Meharwal, Y. K. Mishra, V. Kohli, R. Bapna, S. Singh, and N. Trehan Off-pump multivessel coronary artery surgery in high-risk patients Ann. Thorac. Surg., October 1, 2002; 74(4): S1353 - S1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gurevitch, Y. Paz, I. Shapira, M. Matsa, A. Kramer, D. Pevni, O. Lev-Ran, Y. Moshkovitz, and R. Mohr Routine use of bilateral skeletonized internal mammary arteries for myocardial revascularization Ann. Thorac. Surg., August 1, 1999; 68(2): 406 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Roques, S. A. M. Nashef, P. Michel, E. Gauducheau, C. de Vincentiis, E. Baudet, J. Cortina, M. David, A. Faichney, F. Gavrielle, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients Eur J Cardiothorac Surg, June 1, 1999; 15(6): 816 - 823. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |